These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19587356)

  • 1. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
    Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
    Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
    Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
    Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
    Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
    Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of retinoic acid in experimental diabetic nephropathy.
    Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
    Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
    Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G
    Diabetes; 2010 Apr; 59(4):1046-54. PubMed ID: 20068137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.
    Nam BY; Paeng J; Kim SH; Lee SH; Kim DH; Kang HY; Li JJ; Kwak SJ; Park JT; Yoo TH; Han SH; Kim DK; Kang SW
    Apoptosis; 2012 Jan; 17(1):1-13. PubMed ID: 22006533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.
    Burt D; Salvidio G; Tarabra E; Barutta F; Pinach S; Dentelli P; Camussi G; Perin PC; Gruden G
    Am J Pathol; 2007 Dec; 171(6):1789-99. PubMed ID: 18055544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
    Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells.
    Giunti S; Tesch GH; Pinach S; Burt DJ; Cooper ME; Cavallo-Perin P; Camussi G; Gruden G
    Diabetologia; 2008 Jan; 51(1):198-207. PubMed ID: 17968528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
    Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
    J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin I2 Receptor Agonism Preserves β-Cell Function and Attenuates Albuminuria Through Nephrin-Dependent Mechanisms.
    Batchu SN; Majumder S; Bowskill BB; White KE; Advani SL; Brijmohan AS; Liu Y; Thai K; Azizi PM; Lee WL; Advani A
    Diabetes; 2016 May; 65(5):1398-409. PubMed ID: 26868296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.
    Lee EY; Chung CH; Khoury CC; Yeo TK; Pyagay PE; Wang A; Chen S
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F85-94. PubMed ID: 19420107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of nephrin according to glomerular size in early diabetic kidney disease.
    Kim JJ; Li JJ; Jung DS; Kwak SJ; Ryu DR; Yoo TH; Han SH; Choi HY; Kim HJ; Han DS; Kang SW
    J Am Soc Nephrol; 2007 Aug; 18(8):2303-10. PubMed ID: 17599973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Mafb in podocytes protects against diabetic nephropathy.
    Morito N; Yoh K; Ojima M; Okamura M; Nakamura M; Hamada M; Shimohata H; Moriguchi T; Yamagata K; Takahashi S
    J Am Soc Nephrol; 2014 Nov; 25(11):2546-57. PubMed ID: 24722438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone.
    Miceli I; Burt D; Tarabra E; Camussi G; Perin PC; Gruden G
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F381-90. PubMed ID: 19906946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.